Covered recipient · General Payments record
ROSE KIHARA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,509.29
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $485.25 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $225.62 | 16 |
| Acerta Pharma LLC | $125.00 | 1 |
| Actelion Pharmaceuticals US, Inc. | $120.24 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.74 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460266 | CMS |
| ABBVIE INC. | $6.06 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460268 | CMS |
| ABBVIE INC. | $9.05 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460270 | CMS |
| ABBVIE INC. | $9.39 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460272 | CMS |
| ABBVIE INC. | $9.75 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460274 | CMS |
| ABBVIE INC. | $13.81 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460276 | CMS |
| ABBVIE INC. | $4.29 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460278 | CMS |
| ABBVIE INC. | $74.45 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460280 | CMS |
| ABBVIE INC. | $2.82 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460282 | CMS |
| ABBVIE INC. | $14.28 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460284 | CMS |
| ABBVIE INC. | $16.77 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460286 | CMS |
| ABBVIE INC. | $2.93 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460288 | CMS |
| ABBVIE INC. | $18.54 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460290 | CMS |
| ABBVIE INC. | $11.49 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460292 | CMS |
| ABBVIE INC. | $8.55 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460294 | CMS |
| ABBVIE INC. | $12.70 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107460296 | CMS |
| Actelion Pharmaceuticals US, Inc. | $120.24 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078875098 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104427691 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.39 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153459827 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.